{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Little Rock",
      "state": "AR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72028",
      "recalling_firm": "Cantrell Drug Company",
      "address_1": "7321 Cantrell Rd",
      "address_2": "N/A",
      "postal_code": "72207-4144",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1159-2016",
      "product_description": "HEParin Sodium 0.5 USP UNITS/mL in 0.225% SODIUM CHLORIDE, in 3 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992212",
      "product_quantity": "352 syringes",
      "reason_for_recall": "Stability Data Does Not Support Expiry",
      "recall_initiation_date": "20150821",
      "center_classification_date": "20160706",
      "termination_date": "20170203",
      "report_date": "20160713",
      "code_info": "Lot: 150090, exp 12/24/15"
    }
  ]
}